Literature DB >> 564994

Atypical mycobacteria and the xenograft valve.

D H Tyras, G C Kaiser, H B Barner, L F Laskowski, J J Marr.   

Abstract

During a 4 month interval, cultures taken at the time of porcine xenograft valve implantation grew a fastidious atypical mycobacterium, Mycobacterium chelonei (Runyon's groups IV), in eight of 20 patients. Initial growth occurred at 2 to 3 weeks in thioglycollate broth only; detailed biochemical and bacteriologic evaluation demonstrates altered catalase activity accounting for its initial slow growth. Only one patient has manifested clinical evidence of infection 5 months after mitral valve replacement. A large pericardial effusion required pericardiectomy. Pericardial tissue and fluid have grown M. chelonei with the same growth characteristics as the initial valve culture. It is recommended that manufacturers of xenograft valve bioprostheses maintain a quarantine of 6 weeks until cultures, smears of culture broth, and microscopic evaluation of aortic wall coupons are negative. Users of these prostheses should keep cultures for a minimum of 3 weeks. Should positive cultures result, antimicrobial therapy should be considered only with clinical evidence of infection.

Entities:  

Mesh:

Year:  1978        PMID: 564994

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

Review 1.  Outbreaks associated with contaminated antiseptics and disinfectants.

Authors:  David J Weber; William A Rutala; Emily E Sickbert-Bennett
Journal:  Antimicrob Agents Chemother       Date:  2007-10-01       Impact factor: 5.191

2.  Infections caused by opportunistic mycobacteria.

Authors:  W H Wain; W I Gordon; M Haydon
Journal:  J R Soc Med       Date:  1986-09       Impact factor: 5.344

3.  Mycobacterial prosthetic valve endocarditis.

Authors:  Larry M Bush; Anil Paturi; Fredy Chaparro-Rojas; Maria T Perez
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

4.  Identification of clinically significant Mycobacterium fortuitum complex isolates.

Authors:  V A Silcox; R C Good; M M Floyd
Journal:  J Clin Microbiol       Date:  1981-12       Impact factor: 5.948

Review 5.  Mycobacterial endocarditis: a comprehensive review.

Authors:  Shi-Min Yuan
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.